In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 30 for your search:
Drug:  recombinant interleukin-4
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: NCI-86-C-183E, NCI-T86-0225N, T86-0225
2.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: AECM-9102059, NCI-T91-0050D, T91-0050
3.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: PCI-9038, NCI-T91-0133O, T91-0133
4.

Phase: Phase II
Type: Treatment
Status: Closed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9219
5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: ECOG-E5Y92, E5Y92
6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SPRI-C94-049, SCH-C94-049-01, NCI-V95-0654
7.

Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: SPRI-C94-048, SCH-C94-048-01, NCI-V95-0655
8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 16
Sponsor: NCI
Protocol IDs: SWOG-9711, S9711
9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: RPCI-DS-95-10, NCI-V97-1360
10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: LAC-USC-10M991, NCI-G00-1837, NCI-T99-0102, NCT00006113, T99-0102
11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCF-RPC-3209, NCI-T89-0218O, T89-0218
12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-89-C-166, NCI-T89-0119N, T89-0119
13.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: IDB-IL4/MELANOMA, AECM-9003063, CHNMC-COH-9002390031, LUMC-2347, NEMCH-CSU-1919, UCSF-H6042-05366-01, UTHSC-8905011208, NCI-T90-0030O, T90-0030
14.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: IDB-IL4/RENAL, AECM-9003064, CHNMC-COH-9002290041, LUMC-2348, NEMCH-CSU-1918, UTHSC-8905011209, NCI-T90-0032O, T90-0032
15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: over 1 to under 21
Sponsor: NCI
Protocol IDs: NCI-90-C-210B, NCI-T90-0110N, T90-0110
16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCF-RPC-3209R, NCI-T92-0172O, T92-0172
17.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 to 70
Sponsor: NCI
Protocol IDs: UARK-91005, NCI-T91-0115O, T91-0115
18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WSU-C-1041-92, NCI-T92-0167D, T92-0167
19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CWRCC-ICC-1A92, NCI-T92-0161D, T92-0161
20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9230
21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9228
22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-917851, NCCTG-91-78-51
23.

Phase: Phase I
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: SJCRH-IL4, NCI-T94-0101D, T94-0101
24.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-9574
25.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI
Protocol IDs: NCI-88-C-141B, NCI-T88-0161N, T88-0161
1   
New Search